Eleving Group, a global multi-brand fintech company, announces the settlement of its EUR 40 mln 13% Senior Secured and Guaranteed 2023/2028 Eurobonds (ISIN DE000A3LL7M4) with a 10% Yield to Maturity ...

In addition, IGNITE met the endpoint of revised Investigator's Global Assessment (rIGA) score of 0/1 with ... and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by ...

Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) today announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an investigational T ...

and TOKYO, March 8, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Kyowa Kirin Co ... of revised Investigator's Global Assessment (rIGA™) score of 0/1 with a ≥2-point reduction from baseline ...

and TOKYO, March 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co ... placebo (p<0.001). For rIGA 0/1, 23.3% of SHUTTLE patients in the higher dose group achieved the endpoint ...

RE Excellence is one of the leading real estate developers in Vilnius, specializing in high-quality projects in the most attractive areas of the city, including the Old Town. The company's portfolio ...

Amgen and Kyowa Kirin's rocatinlimab showed strong efficacy in Phase 3 trials for atopic dermatitis, achieving key endpoints ...

2-Year U.S. Treasury Note Continuous Contract $103.551 0.086 0.08% 5-Year U.S. Treasury Note Continuous Contract $107.930 0.203 0.19% 10-Year U.S. Treasury Note Continuous Contract $110.922 0.281 ...

All the key secondary endpoints of the trial were met, demonstrating the “statistical significance” of the therapy.

Bond Eleving Group issues EUR 40 mln tap on 2023/2028 bonds with an issue price of 109% / 09:00 CET/CEST The issuer ...

CAESAREA, Israel and RIGA, Latvia, March 11, 2025 /PRNewswire/ -- Latvenergo, Latvia's national electricity company, and H2Pro, an Israeli innovator in green hydrogen production, have signed a ...